{
    "2015-02-20": [
        "@pharmamaven amazing run you had over the last year $CELG $ACAD $TGTX $ZIOP $CRMD $OMED",
        "$CELG/Inhibrx anti-CD47 mAb CC-90002 PhI trial finally posted (N=100) $TRIL",
        "Celgene's REVLIMID approved by the European Commission for treatment of adults with untreated multiple myeloma. ($CELG)"
    ]
}